Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.145
+0.005 (0.44%)
At close: Sep 17, 2026, 4:00 PM EDT
1.140
-0.005 (-0.44%)
After-hours: Sep 17, 2026, 4:10 PM EDT
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $22.06 million as of September 17, 2026. Its market cap has increased by 63.38% in one year.
Market Cap
22.06M
Enterprise Value
21.23M
1-Year Change
63.38%
Ranking
Category
Stock Price
$1.15
ChartMarket Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $22.06M, a decrease of -80.87%. That is a compound annual growth rate of -17.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 22.06M | 63.38% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NanoViricides | 23.92M |
| Polyrizon | 23.82M |
| Psyence Biomedical | 22.89M |
| Palatin Technologies | 22.42M |
| PDS Biotechnology | 22.34M |
| Longeveron | 22.06M |
| Lantern Pharma | 21.86M |
| Cellectar Biosciences | 21.83M |